search
Back to results

Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses

Primary Purpose

Myopia, Orthokeratology

Status
Completed
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Breath-O orthokeratology lenses
Sponsored by
The Hong Kong Polytechnic University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia focused on measuring Myopia, Myopia Control, Orthokeratology, Electroretinogram, Multifocal Electroretinogram

Eligibility Criteria

8 Years - 12 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Refractive error: Spherical: -1.00D to -4.00D; Cylindrical: half of Sph (against-the-rule Astig.: less than -0.75D)
  • Best corrected Visual acuity: monocular ETDRS 0.1 or better

Exclusion Criteria:

  • Ocular abnormality
  • Contra-indicated for overnight orthokeratology lens wear
  • History of refractive surgery
  • Systemic diseases
  • History of orthokeratology lenses wearing or other myopia control methods

Sites / Locations

  • School of Optometry, Hong Kong Polytechnic University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

OrthoK (orthokeratology)

SV Lenses (Single vision)

Arm Description

Group wearing Breath-O corrected orthokeratology lenses for 2 years

Group wearing spectacle with single vision lenses for 2 years

Outcomes

Primary Outcome Measures

Subjective Refraction
Refractive Error ( in Diopter )

Secondary Outcome Measures

Axial Length
Length of eye ball

Full Information

First Posted
April 16, 2019
Last Updated
February 27, 2023
Sponsor
The Hong Kong Polytechnic University
Collaborators
SEED Co. Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT03919396
Brief Title
Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses
Official Title
Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses in Different Myopia Progression Groups
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
April 1, 2019 (Actual)
Primary Completion Date
October 31, 2019 (Actual)
Study Completion Date
December 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Hong Kong Polytechnic University
Collaborators
SEED Co. Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a 24-month longitudinal randomized controlled trial aiming to evaluate the effectiveness of myopia control by Breath-O correct orthokeratology lenses in different myopia progression groups classified according to their initial electro-retinal responses.
Detailed Description
Myopia is the most common refractive error in the world. In Hong Kong, the number of children in myopia is on the rise and approximately 80% of children are myopic by the end of childhood. Orthokeratology is one of the most successful myopia control methods adopting the strategy of peripheral defocus, in which the natural emmetropization process is harnessed by the myopic defocus induced by the orthokeratology lenses.Currently, Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with higher elasticity as compared traditional lens material. A recent study has shown young children with an initial weakened central electrical signal from the inner retina had faster myopia progression as measured by multifocal electroretinogram(ERG). We will classify the slow and fast progression group based on the ERG results, so as to evaluate the clinical effectiveness of the newly designed lenses in controlling myopia in children with different rates of progression.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia, Orthokeratology
Keywords
Myopia, Myopia Control, Orthokeratology, Electroretinogram, Multifocal Electroretinogram

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized clinical trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
91 (Actual)

8. Arms, Groups, and Interventions

Arm Title
OrthoK (orthokeratology)
Arm Type
Experimental
Arm Description
Group wearing Breath-O corrected orthokeratology lenses for 2 years
Arm Title
SV Lenses (Single vision)
Arm Type
No Intervention
Arm Description
Group wearing spectacle with single vision lenses for 2 years
Intervention Type
Device
Intervention Name(s)
Breath-O orthokeratology lenses
Intervention Description
Specially designed rigid gas permeable lenses which reshapes corneal profile for myopia control has higher elasticity compared to traditional lens material.
Primary Outcome Measure Information:
Title
Subjective Refraction
Description
Refractive Error ( in Diopter )
Time Frame
up to 24 months
Secondary Outcome Measure Information:
Title
Axial Length
Description
Length of eye ball
Time Frame
up to 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Refractive error: Spherical: -1.00D to -4.00D; Cylindrical: half of Sph (against-the-rule Astig.: less than -0.75D) Best corrected Visual acuity: monocular ETDRS 0.1 or better Exclusion Criteria: Ocular abnormality Contra-indicated for overnight orthokeratology lens wear History of refractive surgery Systemic diseases History of orthokeratology lenses wearing or other myopia control methods
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Henry HL Chan, PhD
Organizational Affiliation
The Hong Kong Polytechnic University
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Optometry, Hong Kong Polytechnic University
City
Hong Kong
ZIP/Postal Code
00000
Country
Hong Kong

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses

We'll reach out to this number within 24 hrs